Literature DB >> 12655548

Genetic diversity within the R408W phenylketonuria mutation lineages in Europe.

Orna Tighe1, Donncha Dunican, Charles O'Neill, Giorgio Bertorelle, Diane Beattie, Colin Graham, Johannes Zschocke, Francesco Cali, Valentino Romano, Eva Hrabincova, Libor Kozak, Marina Nechyporenko, Ludmilla Livshits, Per Guldberg, Monika Jurkowska, Cezary Zekanowski, Belen Perez, Lourdes Ruiz Desviat, Magdalena Ugarte, Vaidutis Kucinskas, Per Knappskog, Eileen Treacy, Eileen Naughten, Linda Tyfield, Susan Byck, Charles R Scriver, Philip D Mayne, David T Croke.   

Abstract

The R408W phenylketonuria mutation in Europe has arisen by recurrent mutation in the human phenylalanine hydroxylase (PAH) locus and is associated with two major PAH haplotypes. R408W-2.3 exhibits a west-to-east cline of relative frequency reaching its maximum in the Balto-Slavic region, while R408W-1.8 exhibits an east-to-west cline peaking in Connacht, the most westerly province of Ireland. Spatial autocorrelation analysis has demonstrated that the R408W-2.3 cline, like that of R408W-1.8, is consistent with a pattern likely to have been established by human dispersal. Genetic diversity within wild-type and R408W chromosomes in Europe was assessed through variable number tandem repeat (VNTR) nucleotide sequence variation and tetranucleotide short tandem repeat (STR) allelic associations. Wild-type VNTR-8 chromosomes exhibited two major cassette sequence organizations: (a1)5-b3-b2-c1 and (a1)5-b5-b2-c1. R408W-1.8 was predominantly associated with (a1)5-B5-B2-C1. Both wild-type vntr-3 and r408w-2.3 chromosomes exhibited a single invariant cassette sequence organization, a2-b2-c1. STR allele distributions associated with the cassette variants were consistent with greater diversity in the wild-type VNTR-8 lineage and were suggestive of different levels of diversity between R408W-1.8 and R408W-2.3. The finding of greater genetic diversity within the wild-type VNTR-8 lineage compared to VNTR-3 suggests that VNTR-8 may be older within the European population. However, in the absence of a more extensive STR data-set, no such conclusions are possible for the respective R408W mutant lineages. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655548     DOI: 10.1002/humu.10195

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  8 in total

1.  Hyperphenylalaninaemias in Estonia: Genotype-Phenotype Correlation and Comparative Overview of the Patient Cohort Before and After Nation-Wide Neonatal Screening.

Authors:  Hardo Lilleväli; Karit Reinson; Kai Muru; Kristi Simenson; Ülle Murumets; Tõnu Möls; Katrin Õunap
Journal:  JIMD Rep       Date:  2017-09-28

2.  Molecular genetics of a cohort of 635 cases of phenylketonuria in a consanguineous population.

Authors:  Tina Shirzadeh; Amir Hossein Saeidian; Hamideh Bagherian; Shadab Salehpour; Aria Setoodeh; Mohammad Reza Alaei; Leila Youssefian; Ashraf Samavat; Andrew Touati; Mohammad-Sadegh Fallah; Hassan Vahidnezhad; Morteza Karimipoor; Sarah Azadmehr; Marzieh Raeisi; Ameneh Bandehi Sarhadi; Fatemeh Zafarghandi Motlagh; Mojdeh Jamali; Zahra Zeinali; Maryam Abiri; Sirous Zeinali
Journal:  J Inherit Metab Dis       Date:  2018-08-29       Impact factor: 4.982

3.  Association Between PAH Mutations and VNTR Alleles in the West Azerbaijani PKU Patients.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Rasoul Zarrin; Ahad Ghazavi
Journal:  Maedica (Buchar)       Date:  2014-09

4.  Genotypes of 2579 patients with phenylketonuria reveal a high rate of BH4 non-responders in Russia.

Authors:  Polina Gundorova; Anna A Stepanova; Irina A Kuznetsova; Sergey I Kutsev; Aleksander V Polyakov
Journal:  PLoS One       Date:  2019-01-22       Impact factor: 3.240

5.  Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.

Authors:  Yury A Barbitoff; Rostislav K Skitchenko; Olga I Poleshchuk; Anton E Shikov; Elena A Serebryakova; Yulia A Nasykhova; Dmitrii E Polev; Anna R Shuvalova; Irina V Shcherbakova; Mikhail A Fedyakov; Oleg S Glotov; Andrey S Glotov; Alexander V Predeus
Journal:  Mol Genet Genomic Med       Date:  2019-09-03       Impact factor: 2.183

6.  Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing.

Authors:  Robert A Kaiser; Daniel F Carlson; Kari L Allen; Dennis A Webster; Caitlin J VanLith; Clara T Nicolas; Lori G Hillin; Yue Yu; Catherine W Kaiser; William R Wahoff; Raymond D Hickey; Adrienne L Watson; Shelley R Winn; Beat Thöny; Douglas R Kern; Cary O Harding; Joseph B Lillegard
Journal:  PLoS One       Date:  2021-01-25       Impact factor: 3.240

7.  The analysis of using a panel of the most common variants in the PAH gene for the newborn screening in Ukraine.

Authors:  Liliya Fishchuk; Zoia Rossokha; Natalia Olkhovich; Nataliia Pichkur; Olena Popova; Nataliia Medvedieva; Viktoriia Vershyhora; Olha Dubitska; Tetiana Shkurko; Larysa Popovych; Olga Bondar; Irina Morozuk; Svitlana Onyshchenko; Lyubov Yevtushok; Oksana Tsizh; Iryna Bryl; Olena Tul; Svitlana Kalynka; Iryna Zinkina; Svitlana Matviiuk; Yulianna Riabova; Nataliia Gorovenko
Journal:  Mol Genet Metab Rep       Date:  2022-08-01

8.  Analysis of EX5del4232ins268 and EX5del955 PAH gene mutations in Ukrainian patients with phenylketonuria.

Authors:  Volodymyr Pampukha; Maryna Nechyporenko; Ludmila Livshyts
Journal:  Genes Dis       Date:  2016-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.